[IOICORP] YoY Quarter Result on 31-Dec-2019 [#2]

Stock
[IOICORP] IOI CORPORATION BHD
Announcement Date
18-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2020
Quarter
31-Dec-2019 [#2]
Profit Trend
QoQ- 43.29%
YoY- 9.21%
Quarter Report
Latest QR
Upcoming QR
IOICORP's Result
IOICORP's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 3,304,000 4,112,300 2,454,700 1,955,200 1,880,600 2,399,800 2,506,500 4.70%
PBT 857,000 666,500 430,000 269,300 239,000 622,900 52,500 59.23%
Tax -141,900 -158,700 -67,200 -55,400 -43,400 -19,800 -25,900 32.75%
NP 715,100 507,800 362,800 213,900 195,600 603,100 26,600 73.03%
-
NP to SH 712,100 494,700 355,700 213,500 195,500 595,900 15,600 88.99%
-
Tax Rate 16.56% 23.81% 15.63% 20.57% 18.16% 3.18% 49.33% -
Total Cost 2,588,900 3,604,500 2,091,900 1,741,300 1,685,000 1,796,700 2,479,900 0.71%
-
Net Worth 11,237,384 10,326,859 9,587,591 9,301,273 9,175,303 7,980,552 7,168,433 7.77%
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 372,510 373,260 281,988 251,385 219,955 282,775 282,964 4.68%
Div Payout % 52.31% 75.45% 79.28% 117.75% 112.51% 47.45% 1,813.88% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 11,237,384 10,326,859 9,587,591 9,301,273 9,175,303 7,980,552 7,168,433 7.77%
NOSH 6,258,100 6,258,100 6,285,198 6,284,643 6,284,453 6,283,900 6,461,000 -0.53%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 21.64% 12.35% 14.78% 10.94% 10.40% 25.13% 1.06% -
ROE 6.34% 4.79% 3.71% 2.30% 2.13% 7.47% 0.22% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 53.22 66.10 39.17 31.11 29.92 38.19 39.86 4.93%
EPS 11.47 7.95 5.68 3.40 3.11 9.48 0.25 89.15%
DPS 6.00 6.00 4.50 4.00 3.50 4.50 4.50 4.90%
NAPS 1.81 1.66 1.53 1.48 1.46 1.27 1.14 8.00%
Adjusted Per Share Value based on latest NOSH - 6,284,643
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 53.28 66.31 39.58 31.53 30.32 38.70 40.42 4.70%
EPS 11.48 7.98 5.74 3.44 3.15 9.61 0.25 89.17%
DPS 6.01 6.02 4.55 4.05 3.55 4.56 4.56 4.70%
NAPS 1.812 1.6652 1.546 1.4998 1.4795 1.2869 1.1559 7.77%
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 4.05 3.73 4.37 4.61 4.45 4.54 4.40 -
P/RPS 7.61 5.64 11.16 14.82 14.87 11.89 11.04 -6.01%
P/EPS 35.31 46.91 76.99 135.70 143.05 47.88 1,773.57 -47.92%
EY 2.83 2.13 1.30 0.74 0.70 2.09 0.06 90.02%
DY 1.48 1.61 1.03 0.87 0.79 0.99 1.02 6.39%
P/NAPS 2.24 2.25 2.86 3.11 3.05 3.57 3.86 -8.66%
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 28/02/23 23/02/22 23/02/21 18/02/20 20/02/19 23/02/18 20/02/17 -
Price 3.83 4.42 4.24 4.50 4.73 4.79 4.63 -
P/RPS 7.20 6.69 10.82 14.46 15.81 12.54 11.62 -7.66%
P/EPS 33.39 55.58 74.70 132.46 152.05 50.51 1,866.28 -48.84%
EY 2.99 1.80 1.34 0.75 0.66 1.98 0.05 97.68%
DY 1.57 1.36 1.06 0.89 0.74 0.94 0.97 8.35%
P/NAPS 2.12 2.66 2.77 3.04 3.24 3.77 4.06 -10.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment